| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f113b13080aab1975c878e0cd08b0b1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1694
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate |
2015-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_014785787f254160265712b416110473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ec3a0192708e3a07d7a07ed88fce806 |
| publicationDate |
2015-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2915526-A1 |
| titleOfInvention |
Pharmaceutical compositions comprising anagrelide |
| abstract |
The present invention relates to pharmaceutical compositions comprising anagrelide hydrochloride monohydrate, as well as to a process for the manufacture of said pharmaceutical compositions and to the use of said pharmaceutical compositions for the treatment of essential thrombocythemia. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4213815-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021036937-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022060309-A1 |
| priorityDate |
2014-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |